Opsoclonus myoclonus ataxia syndrome due to SARS-coV-2

J Finsterer, FA Scorza - Neuro-Ophthalmology, 2023 - Taylor & Francis
Opsoclonus myoclonus syndrome (OMS)/opsoclonus myoclonus ataxia syndrome (OMAS),
also known as Kinsbourne's syndrome or 'dancing eyes-dancing feet'syndrome, is a rare …

[HTML][HTML] De novo movement disorders associated with COVID-19-A systematic review of individual patients

KS Pillai, S Misra, G Siripurapu, A Aliyar… - Annals of Indian …, 2023 - journals.lww.com
Background: COVID-19 infection is associated with neurological manifestations, including
various types of movement disorders (MD). A thorough review of individual patients with …

Anti-GAD associated post-infectious cerebellitis after COVID-19 infection

AS Emekli, A Parlak, NY Göcen, M Kürtüncü - Neurological Sciences, 2021 - Springer
Abstract The coronavirus disease 2019 (COVID-19), caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread rapidly all over the …

Movement disorders and SARS‐CoV‐2

WKW Fung, A Fasano, C Fearon - … Disorders Clinical Practice, 2022 - pmc.ncbi.nlm.nih.gov
As we have entered the third year of the coronavirus disease 2019 (COVID-19) pandemic, it
has become increasingly difficult to summarize all aspects of severe acute respiratory …

Temporal changes in brain perfusion in a patient with myoclonus and ataxia syndrome associated with COVID-19

K Osawa, A Sugiyama, A Uzawa, S Hirano… - Internal …, 2022 - jstage.jst.go.jp
Myoclonus and ataxia, with or without opsoclonus, have recently been recognized as a
central nervous system syndrome associated with coronavirus disease-2019 (COVID-19). A …

Efferent neuro-ophthalmic complications of coronavirus disease 2019

M Dinkin, S Sathi - Current Opinion in Ophthalmology, 2022 - journals.lww.com
Observed neuro-ophthalmic associations need to be confirmed through larger comparative
studies. Meanwhile, the range of possible complications should be recognized by …

Opsoclonus-myoclonus-ataxia syndrome due to Covid-19

M Adamaszek, S Langner, J Mehrholz, A Heiinrich - The Cerebellum, 2024 - Springer
Opsoclonus-myoclonus syndrome (OMS) as a rare neurological encephalopathic entity
associated with non-specific infections or cancer processes has been repeatedly described …

Autoimmune mediated hyperkinetic movement disorders in SARS-CoV-2 infection—a systematic review

AS Hirschfeld - Neurologia i Neurochirurgia Polska, 2021 - journals.viamedica.pl
Introduction. Various neurological symptoms have been confirmed in the course of SARS-
CoV-2 infection. Some of these are undoubtedly the aftermath of the developing …

Hyperkinetic movement disorders following SARS-CoV-2 infection and vaccination—an update

F Przytuła, J Sławek - Neurologia i Neurochirurgia Polska, 2023 - journals.viamedica.pl
The aim of this review was to summarise current knowledge regarding hyperkinetic
movement disorders related to SARS-CoV-2 infection and vaccination in terms of …

A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome

A Altunsoy, N Kemirtlek, H Araz, EB Dirik… - The Journal of Infection in …, 2024 - jidc.org
Abstract Introduction: Coronavirus disease 2019 (COVID-19) can have symptoms like many
neurological diseases, and one of the rare forms of these presentations is opsoclonus …